Combination Therapy for EGFR-Mutated Lung Cancer

N Engl J Med. 2023 Nov 23;389(21):2005-2007. doi: 10.1056/NEJMe2311559. Epub 2023 Nov 8.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Drug Therapy, Combination
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • EGFR protein, human
  • ErbB Receptors
  • Protein Kinase Inhibitors